Docs, Let me ask you something straight-up: Have you ever bought a stock, watched it tank, and sworn off investing for good? If you nodded yes, you’re in good company. Plenty of new investors have been burned by a bad pick and felt the sting so deeply they walked away from the market entirely. But I’m here to tell you—it doesn’t have to end like that. Even the legendary Warren Buffett has made his fair share of investing mistakes, more than you might think.
Buffett’s mentor, Ben Graham, wrote in his classic Security Analysis that investing in stocks is a bit like running an insurance business. When an insurance underwriter writes policies, they know some folks will get sick and cost them money—sometimes a lot. But the ones who stay healthy? They balance the books, often tipping the scales into profit. Investing works the same way. No matter how sharp your risk management or stock-picking skills, some stocks in your portfolio will flop. Others, though, will soar, and those winners—sometimes multiplying several times over—can more than make up for the losses, delivering a net gain.
Take our recent experience with G1 Therapeutics (GTHX) as an example. In June 2024, their breast cancer drug, trilaciclib (Cosela), flopped in a late-stage trial, sending the stock into a tailspin. This wasn’t the first hiccup—back in February 2023, G1 halted a Phase 3 trial for colorectal cancer, even though it hit some endpoints, causing a brutal 52% pre-market drop. Despite my best efforts, I misjudged the clinical trial outcomes, and we took a hit. After digging into the company’s growth prospects, I decided to sell and lock in a realized loss of -$15,208.20. Normally, I don’t sell when a stock’s down, but with Cosela’s breast cancer indication failing, GTHX’s growth potential looked dim. Since it was a high-risk, speculative play, we kept the position small, which capped our loss. Our winners still allowed us to outperformed the market as indicated by our 31.96% net audited returns for FY24.
Here’s the thing: don’t let a loss like this scare you out of the game. Accept it, learn from it, and keep going. Your winners will outweigh the losers over time, giving you an overall gain. That’s how you make your money work for you—without trading your hours for dollars.
Keep investing smarter!
Why Keep Trading Hours for Dollars?
You pour countless hours into your clinic or hospital, saving lives but often sacrificing your own—your health, your family, your freedom. You’re trading precious time for dollars, with little left for travel or the life you want.
So, let me ask you:
- Would more time and money let you live better?
- What if you could change that?
- What if you leveraged your medical expertise to make your hard-earned dollars grow through smart investing?
- Would working smarter, not harder, transform your life?
- How about having a voice in investments that grow your wealth and help your patients?
If any of these hit home, our biotech hedge fund (Evergrowth BioHealthcare Capital)—designed by doctors, for doctors—might be your answer. Here’s what you’d gain by joining us:
- Invest in what you know, using your clinical edge.
- Grow your wealth into generational riches for you and your kids.
- Work fewer hours as your investments take off.
- Retire early to travel and live more.
- Prioritize your health and happiness.
- Connect with other physician investors.
- Support innovations that bring hope to patients on a massive scale.
- Become a Medical Advisor (just one hour a month commitment).
- We only get a small share of your profits, if and only if, we can beat the 8% average stock market performance for you.
Visit us at https://evergrowthinvest.com/presentation/.
Join our Skool page at https://www.skool.com/evergrowthbiohealthcarecapital
Schedule a free consultation with me to see if we are the right fit https://calendly.com/drharveytran/evergrowth-introduction?month=2025-05.
Disclaimer: This blog is for educational and informational purposes only. It’s not a recommendation to buy, sell, or hold any stock. Always consult your investment advisor and do your due diligence before investing.
Disclosure: We owned and liquidated our shares of GTHX.
More recent blogs for you:
